Samantha Pearce, SVP, Head of Europe & Internat at Jazz Pharmaceuticals plc (JAZZ), sold 8,487 shares at $155.00 ($1.3M) on 2022-06-08, disclosed to the SEC on 2022-06-10.
Open-market sale of $1.3M JAZZ by SVP, Head of Europe & Internat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.00 | 2,652 | $411K | 31.2% |
| 2 | $155.00 | 5,835 | $904K | 68.8% |
| Total | $155.00 avg | 8,487 | $1.3M | 100% |
| Filing → |
| JAZZ | SELL | 2023-01-05 | $169K | — | Filing → |
| JAZZ | SELL | 2022-12-15 | $165K | — | Filing → |
| JAZZ | SELL | 2022-11-14 | $165K | — | Filing → |